Sunday, January 24, 2021

Tag: veterinarian

Defensive Stocks to own before the Election

On August 14, Pet Vivo Holdings, Inc. (OTCQB: PETV) filed its quarterly report for the period ending June 30, 2020. In it, it showed current liabilities of $2.14 million. Since then, the company settled over $600,000.00 in liabilities which is reflected in recent 8K “material event” filings, as well as in its next quarterly report.

A low float Biotech that’s ahead of the Curve; Focus on...

Back in July, the stock was given a target price of between $1.74 and $2.32 per share by Marble Arch Research. You can download the full report here: - Among other results, the report states “At ~1x FY23 sales, the stock is substantially undervalued relative to its comps mostly trading in a comparable 3X-4X P/S multiple range.”

A niche company in biotech could prove to be the biggest...

Recently trading at around .70 per share, PetVivo Holdings, Inc. (OTCQB: PETV) just announced something interesting on Tuesday which brought a $1.40 share price and what could be the beginning of a strong accumulation of their stock.

Analysts are positive on these top Medical Technology and Healthcare stocks...

The new PetVivo medical device facility, primarily dedicated to the manufacture of its veterinary medical device for the treatment of osteoarthritis (OA), KUSH™ will serve as the primary location for PetVivo medical device operations, which provides manufacturing capabilities to produce up to 500,000 syringes of Kush that could generate over $100 million in revenue annually.

Healthcare to reduce the cost of medical – It’s not just...

Marble Arch Research notes that PetVivo (OTCQB: PETV)achieved a major funding milestone last month, removing the main obstacle to its product commercialization goals. Commercial production of its disruptive osteoarthritis treatment device, Kush®, for canines and equines, a market we estimate is worth ~$3BN in the US alone, is due to commence in September 2020.

Emerging Growth Report reveals a hidden gem in the Biotech...

Kiplinger recently released an article in titled “5 Booming Biotech Stocks to Buy” It starts off by stating that these stocks are already up over...

Report Reveals an Alternative to Overpriced and Highly Volatile Biotech Stocks

A good gauge as to where an industry is headed is always the ETF’s.  In biotech the top ETF’s according to InvestingNews.com are:  iShares NASDAQ Biotechnology...

Overpriced Biotech St – Where to go if you want to...

A recent article in InvestorPlace last week instructed you to “Sell Overpriiced Novavax Stock While You Still Can”.  Novavax, Inc. (NASDAQ: NVAX), thanks to the...

The best way to Profit in Biotech for the remainder of...

Investors Business Daily recently posted an article about “Finding the best biotech companies to invest in”.  The article goes on to say that investing in...

PetVivo (PETV) Announces Notice of Allowance for United States Patent Application...

Miami, FL – August 6, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging...